Average body weight trends for the four groups during the pre-challenge period. by Oumayma Arbani (21001472)

Subjects:

Trends of average ocular symptom scores during the post-challenge period. by Oumayma Arbani (21001472)

Subjects:

Average histopathological lesions and scores noted in trachea and lungs of birds during post-infection period. by Oumayma Arbani (21001472)

Subjects:

Experimental design used in broiler chickens. by Oumayma Arbani (21001472)

Subjects:

Necropsy lesions of deceased chicks from group B, lesions are presented in yellow arrows. by Oumayma Arbani (21001472)

Subjects:

Microscopical lesions in trachea and lungs H&E staining on dpi 5. by Oumayma Arbani (21001472)

Subjects:

Average body weight trends for the four groups during the post-challenge period. by Oumayma Arbani (21001472)

Subjects:

Microscopical lesions in trachea and lungs H&E staining on dpi 10. A) Moderate to severe subacute tracheitis (score 2) with epithelial hyperplasia (Asterisk) and mixed inflammatory... by Oumayma Arbani (21001472)

Subjects:

Trends of average respiratory symptom scores during the post-challenge period. by Oumayma Arbani (21001472)

Subjects:

Quantitative estimation of viral concentration from qRT-PCR data using a regression equation. by Oumayma Arbani (21001472)

Subjects:

Minimal data set. by Pornpan Chalermkitpanit (22110121)

Subjects:

Univariate and multivariate analysis of variables associated with good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The correlation between clinical presentations and baseline serum inflammatory cytokines before TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The serum concentrations of cytokines between good responders and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

Demographic data and baseline characteristics between good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The correlation between the duration of pain symptoms and baseline serum inflammatory cytokine levels before TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

Supplementary results_detailed. by Pornpan Chalermkitpanit (22110121)

Subjects:

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; ^$(P < 0.05) significant vs. …”

qRT-PCR results of differentially expressed miRNAs in rats’ myocardial tissue after training. by Zhaowen Tan (12283502)